tradingkey.logo

Gelteq Ltd

GELS
0.811USD
+0.005+0.61%
收盘 02/09, 16:00美东报价延迟15分钟
7.75M总市值
亏损市盈率 TTM

Gelteq Ltd

0.811
+0.005+0.61%

关于 Gelteq Ltd 公司

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Gelteq Ltd简介

公司代码GELS
公司名称Gelteq Ltd
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)
员工数量7
证券类型Ordinary Share
年结日Oct 29
公司地址Level 4
城市MELBOURNE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Australia
邮编3205
电话61390873990
网址https://www.gelteq.com
公司代码GELS
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)

Gelteq Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
其他
52.47%
持股股东
持股股东
占比
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
其他
52.47%
股东类型
持股股东
占比
Individual Investor
41.53%
Corporation
6.00%
Investment Advisor
0.53%
Research Firm
0.34%
其他
51.60%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
9
93.11K
0.87%
-18.87K
2025Q3
8
105.80K
1.05%
--
2025Q2
8
105.80K
1.09%
+654.00
2025Q1
5
105.14K
0.84%
+24.19K
2024Q4
3
80.95K
0.00%
+80.95K

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Markoff (Jeffrey)
2.44M
22.79%
--
--
Jun 30, 2025
Golik (David)
1.01M
9.45%
--
--
Jun 30, 2025
Givoni (Nathan Jacob)
657.09K
6.13%
--
--
Jun 30, 2025
Crestmont Pty Ltd
642.32K
6%
--
--
Jun 30, 2025
Szewach (Simon Hayden)
338.20K
3.16%
--
--
Jun 30, 2025
Susquehanna International Group, LLP
41.55K
0.39%
+41.55K
--
Sep 30, 2025
Wedbush Securities, Inc.
20.00K
0.19%
--
--
Sep 30, 2025
Virtu Americas LLC
15.47K
0.14%
+3.23K
+26.42%
Sep 30, 2025
HRT Financial LP
15.44K
0.14%
-29.18K
-65.40%
Sep 30, 2025
Morgan Stanley & Co. LLC
651.00
0.01%
+651.00
--
Sep 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI